Mia Levy, MD, PhD - PI @MiaL
Josh Denny, MD, MS - PI @JoshD
Josh Peterson, MD, MPH - Co-Investigator @JoshP
Marc Beller, PMP, BA - Health IT @MarkB
Jodell Jackson, PhD - Project Manager @JodellJ
Ramya Marathi, MS - Program Coordinator @RamyaM
Laura Wiley, - PhD student (Denny) @LauraW
For decades, Vanderbilt University Medical Center (VUMC) has been at the forefront of pharmacogenomic discovery and its translation into clinical practice. In 2010, VUMC launched both PREDICT (the Pharmacogenomic Resource for Enhanced Decisions in Care & Treatment) and the PCMI (Personalized Cancer Medicine Initiative) to empower providers and patients with the genetic information and electronic medical record tools to facilitate genetically-informed clinical decision-making at the point of care. Within the Integrated, Individualized, Intelligent Prescribing (I3P) Network, VUMC is collaborating with four diverse adopter sites to disseminate the tools developed for PREDICT and the PCMI to tailor therapy based on germline and somatic gene variants of known clinical significance. These sites employ different EMR and e-prescribing systems and include diverse patient populations.